Quibim Announces $50 Million in Series A Financing, led by Asabys and Buenavista, to Revolutionize Precision Medicine with AI-Powered Imaging Biomarkers
January 28, 2025 07:00 AM Eastern Standard Time VALENCIA, Spain & NEW YORK–(BUSINESS WIRE)–Quibim, a leading healthtech company pioneering the use of imaging biomarkers for precision medicine, announced today the close of its $50 million…